aluates Reports

$ 0.0

Automative

Global Protein-based Therapeutics Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-15W16325

Global Protein based Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Protein-based Therapeutics Market Research Report 2025

Code: QYRE-Auto-15W16325

Report

May 2025

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Johnson & Johnson

Novartis

Gilead Sciences

Roche

Bristol–Myers Squibb

Amgen Inc

Astrazeneca plc

Merck

Takeda

Merck KGaA

Seagen

Eli Lilly

Ono Pharmaceutical

Pfizer Inc

Regeneron

Innovent

Hengrui Medicine

Sanofi

SOBI

Kanghong Pharma

Protein-based Therapeutics Market Size

The global market for Protein-based Therapeutics was valued at US$ 258320 million in the year 2024 and is projected to reach a revised size of US$ 498810 million by 2031, growing at a CAGR of 10.0% during the forecast period.

Protein-based Therapeutics Market

Protein therapy is a form of treatment that involves sending in well-structured proteins to a precise target location to repair or replace damaged ones. This is one of the most widely used treatment methods due to its accuracy and lack of negative side effects.

The Protein-based Therapeutics Market is driven by the increasing demand for innovative biopharmaceuticals that utilize proteins as therapeutic agents to treat a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. Protein-based therapies, such as monoclonal antibodies and recombinant proteins, offer highly targeted and precise treatment options. As scientific advancements and personalized medicine gain prominence, the demand for protein-based therapeutics continues to grow. Innovations in protein engineering, drug development, and manufacturing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, high production costs, and regulatory standards while ensuring accessibility and affordability for patients. Overcoming research and development challenges, optimizing drug manufacturing, and adapting to evolving healthcare regulations are ongoing hurdles. Additionally, the market faces competition from small molecules and gene-based therapies, necessitating continuous innovation to unlock the full therapeutic potential of protein-based drugs. Striking a balance between providing safe, effective, and accessible protein-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Protein-based Therapeutics Market.

This report aims to provide a comprehensive presentation of the global market for Protein-based Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein-based Therapeutics.

The Protein-based Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Protein-based Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Protein-based Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Protein-based Therapeutics Market Report

Report Metric	Details
Report Name	Protein-based Therapeutics Market
Accounted market size in year	US$ 258320 million
Forecasted market size in 2031	US$ 498810 million
CAGR	10.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antibody-based Drugs Fc Fusion Proteins Anticoagulants Blood Factors Other
Segment by Application	Immune Diseases Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine, Sanofi, Sobi, Kanghong Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Protein-based Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Protein-based Therapeutics Market growing?

Ans: The Protein-based Therapeutics Market witnessing a CAGR of 10.0% during the forecast period 2025-2031.

What is the Protein-based Therapeutics Market size in 2031?

Ans: The Protein-based Therapeutics Market size in 2031 will be US$ 498810 million.

Who are the main players in the Protein-based Therapeutics Market report?

Ans: The main players in the Protein-based Therapeutics Market are AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine, Sanofi, Sobi, Kanghong Pharma

What are the Application segmentation covered in the Protein-based Therapeutics Market report?

Ans: The Applications covered in the Protein-based Therapeutics Market report are Immune Diseases, Cancer, Other

What are the Type segmentation covered in the Protein-based Therapeutics Market report?

Ans: The Types covered in the Protein-based Therapeutics Market report are Antibody-based Drugs, Fc Fusion Proteins, Anticoagulants, Blood Factors, Other

Recommended Reports

Protein Therapeutics

Gene & Cell Therapy

Disease Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Protein-based Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antibody-based Drugs

1.2.3 Fc Fusion Proteins

1.2.4 Anticoagulants

1.2.5 Blood Factors

1.2.6 Other

1.3 Market by Application

1.3.1 Global Protein-based Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Immune Diseases

1.3.3 Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Protein-based Therapeutics Market Perspective (2020-2031)

2.2 Global Protein-based Therapeutics Growth Trends by Region

2.2.1 Global Protein-based Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Protein-based Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Protein-based Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Protein-based Therapeutics Market Dynamics

2.3.1 Protein-based Therapeutics Industry Trends

2.3.2 Protein-based Therapeutics Market Drivers

2.3.3 Protein-based Therapeutics Market Challenges

2.3.4 Protein-based Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Protein-based Therapeutics Players by Revenue

3.1.1 Global Top Protein-based Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Protein-based Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Protein-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Protein-based Therapeutics Revenue

3.4 Global Protein-based Therapeutics Market Concentration Ratio

3.4.1 Global Protein-based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Protein-based Therapeutics Revenue in 2024

3.5 Global Key Players of Protein-based Therapeutics Head office and Area Served

3.6 Global Key Players of Protein-based Therapeutics, Product and Application

3.7 Global Key Players of Protein-based Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Protein-based Therapeutics Breakdown Data by Type

4.1 Global Protein-based Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Protein-based Therapeutics Forecasted Market Size by Type (2026-2031)

5 Protein-based Therapeutics Breakdown Data by Application

5.1 Global Protein-based Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Protein-based Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Protein-based Therapeutics Market Size (2020-2031)

6.2 North America Protein-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Protein-based Therapeutics Market Size by Country (2020-2025)

6.4 North America Protein-based Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Protein-based Therapeutics Market Size (2020-2031)

7.2 Europe Protein-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Protein-based Therapeutics Market Size by Country (2020-2025)

7.4 Europe Protein-based Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Protein-based Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Protein-based Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Protein-based Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Protein-based Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Protein-based Therapeutics Market Size (2020-2031)

9.2 Latin America Protein-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Protein-based Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Protein-based Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Protein-based Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Protein-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Protein-based Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Protein-based Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Protein-based Therapeutics Introduction

11.1.4 AbbVie Revenue in Protein-based Therapeutics Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Protein-based Therapeutics Introduction

11.2.4 Johnson & Johnson Revenue in Protein-based Therapeutics Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Protein-based Therapeutics Introduction

11.3.4 Novartis Revenue in Protein-based Therapeutics Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Details

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Protein-based Therapeutics Introduction

11.4.4 Gilead Sciences Revenue in Protein-based Therapeutics Business (2020-2025)

11.4.5 Gilead Sciences Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Protein-based Therapeutics Introduction

11.5.4 Roche Revenue in Protein-based Therapeutics Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Protein-based Therapeutics Introduction

11.6.4 Bristol-Myers Squibb Revenue in Protein-based Therapeutics Business (2020-2025)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Amgen

11.7.1 Amgen Company Details

11.7.2 Amgen Business Overview

11.7.3 Amgen Protein-based Therapeutics Introduction

11.7.4 Amgen Revenue in Protein-based Therapeutics Business (2020-2025)

11.7.5 Amgen Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Protein-based Therapeutics Introduction

11.8.4 AstraZeneca Revenue in Protein-based Therapeutics Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Merck & Co

11.9.1 Merck & Co Company Details

11.9.2 Merck & Co Business Overview

11.9.3 Merck & Co Protein-based Therapeutics Introduction

11.9.4 Merck & Co Revenue in Protein-based Therapeutics Business (2020-2025)

11.9.5 Merck & Co Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Protein-based Therapeutics Introduction

11.10.4 Takeda Revenue in Protein-based Therapeutics Business (2020-2025)

11.10.5 Takeda Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Details

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Protein-based Therapeutics Introduction

11.11.4 Merck KGaA Revenue in Protein-based Therapeutics Business (2020-2025)

11.11.5 Merck KGaA Recent Development

11.12 Seagen

11.12.1 Seagen Company Details

11.12.2 Seagen Business Overview

11.12.3 Seagen Protein-based Therapeutics Introduction

11.12.4 Seagen Revenue in Protein-based Therapeutics Business (2020-2025)

11.12.5 Seagen Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Details

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Protein-based Therapeutics Introduction

11.13.4 Eli Lilly Revenue in Protein-based Therapeutics Business (2020-2025)

11.13.5 Eli Lilly Recent Development

11.14 Ono Pharmaceutical

11.14.1 Ono Pharmaceutical Company Details

11.14.2 Ono Pharmaceutical Business Overview

11.14.3 Ono Pharmaceutical Protein-based Therapeutics Introduction

11.14.4 Ono Pharmaceutical Revenue in Protein-based Therapeutics Business (2020-2025)

11.14.5 Ono Pharmaceutical Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Details

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Protein-based Therapeutics Introduction

11.15.4 Pfizer Revenue in Protein-based Therapeutics Business (2020-2025)

11.15.5 Pfizer Recent Development

11.16 Regeneron

11.16.1 Regeneron Company Details

11.16.2 Regeneron Business Overview

11.16.3 Regeneron Protein-based Therapeutics Introduction

11.16.4 Regeneron Revenue in Protein-based Therapeutics Business (2020-2025)

11.16.5 Regeneron Recent Development

11.17 Innovent

11.17.1 Innovent Company Details

11.17.2 Innovent Business Overview

11.17.3 Innovent Protein-based Therapeutics Introduction

11.17.4 Innovent Revenue in Protein-based Therapeutics Business (2020-2025)

11.17.5 Innovent Recent Development

11.18 Hengrui Medicine

11.18.1 Hengrui Medicine Company Details

11.18.2 Hengrui Medicine Business Overview

11.18.3 Hengrui Medicine Protein-based Therapeutics Introduction

11.18.4 Hengrui Medicine Revenue in Protein-based Therapeutics Business (2020-2025)

11.18.5 Hengrui Medicine Recent Development

11.19 Sanofi

11.19.1 Sanofi Company Details

11.19.2 Sanofi Business Overview

11.19.3 Sanofi Protein-based Therapeutics Introduction

11.19.4 Sanofi Revenue in Protein-based Therapeutics Business (2020-2025)

11.19.5 Sanofi Recent Development

11.20 Sobi

11.20.1 Sobi Company Details

11.20.2 Sobi Business Overview

11.20.3 Sobi Protein-based Therapeutics Introduction

11.20.4 Sobi Revenue in Protein-based Therapeutics Business (2020-2025)

11.20.5 Sobi Recent Development

11.21 Kanghong Pharma

11.21.1 Kanghong Pharma Company Details

11.21.2 Kanghong Pharma Business Overview

11.21.3 Kanghong Pharma Protein-based Therapeutics Introduction

11.21.4 Kanghong Pharma Revenue in Protein-based Therapeutics Business (2020-2025)

11.21.5 Kanghong Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Johnson & Johnson

Novartis

Gilead Sciences

Roche

Bristol–Myers Squibb

Amgen Inc

Astrazeneca plc

Merck

Takeda

Merck KGaA

Seagen

Eli Lilly

Ono Pharmaceutical

Pfizer Inc

Regeneron

Innovent

Hengrui Medicine

Sanofi

SOBI

Kanghong Pharma

List of Tables

Table 1. Global Protein-based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antibody-based Drugs

Table 3. Key Players of Fc Fusion Proteins

Table 4. Key Players of Anticoagulants

Table 5. Key Players of Blood Factors

Table 6. Key Players of Other

Table 7. Global Protein-based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Protein-based Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Protein-based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Protein-based Therapeutics Market Share by Region (2020-2025)

Table 11. Global Protein-based Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Protein-based Therapeutics Market Share by Region (2026-2031)

Table 13. Protein-based Therapeutics Market Trends

Table 14. Protein-based Therapeutics Market Drivers

Table 15. Protein-based Therapeutics Market Challenges

Table 16. Protein-based Therapeutics Market Restraints

Table 17. Global Protein-based Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Protein-based Therapeutics Market Share by Players (2020-2025)

Table 19. Global Top Protein-based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein-based Therapeutics as of 2024)

Table 20. Ranking of Global Top Protein-based Therapeutics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Protein-based Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Protein-based Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Protein-based Therapeutics, Product and Application

Table 24. Global Key Players of Protein-based Therapeutics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Protein-based Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Protein-based Therapeutics Revenue Market Share by Type (2020-2025)

Table 28. Global Protein-based Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Protein-based Therapeutics Revenue Market Share by Type (2026-2031)

Table 30. Global Protein-based Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Protein-based Therapeutics Revenue Market Share by Application (2020-2025)

Table 32. Global Protein-based Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Protein-based Therapeutics Revenue Market Share by Application (2026-2031)

Table 34. North America Protein-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Protein-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Protein-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Protein-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Protein-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Protein-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Protein-based Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Protein-based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Protein-based Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Protein-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Protein-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Protein-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Protein-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Protein-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Protein-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 49. AbbVie Company Details

Table 50. AbbVie Business Overview

Table 51. AbbVie Protein-based Therapeutics Product

Table 52. AbbVie Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 53. AbbVie Recent Development

Table 54. Johnson & Johnson Company Details

Table 55. Johnson & Johnson Business Overview

Table 56. Johnson & Johnson Protein-based Therapeutics Product

Table 57. Johnson & Johnson Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 58. Johnson & Johnson Recent Development

Table 59. Novartis Company Details

Table 60. Novartis Business Overview

Table 61. Novartis Protein-based Therapeutics Product

Table 62. Novartis Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 63. Novartis Recent Development

Table 64. Gilead Sciences Company Details

Table 65. Gilead Sciences Business Overview

Table 66. Gilead Sciences Protein-based Therapeutics Product

Table 67. Gilead Sciences Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 68. Gilead Sciences Recent Development

Table 69. Roche Company Details

Table 70. Roche Business Overview

Table 71. Roche Protein-based Therapeutics Product

Table 72. Roche Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 73. Roche Recent Development

Table 74. Bristol-Myers Squibb Company Details

Table 75. Bristol-Myers Squibb Business Overview

Table 76. Bristol-Myers Squibb Protein-based Therapeutics Product

Table 77. Bristol-Myers Squibb Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 78. Bristol-Myers Squibb Recent Development

Table 79. Amgen Company Details

Table 80. Amgen Business Overview

Table 81. Amgen Protein-based Therapeutics Product

Table 82. Amgen Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 83. Amgen Recent Development

Table 84. AstraZeneca Company Details

Table 85. AstraZeneca Business Overview

Table 86. AstraZeneca Protein-based Therapeutics Product

Table 87. AstraZeneca Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 88. AstraZeneca Recent Development

Table 89. Merck & Co Company Details

Table 90. Merck & Co Business Overview

Table 91. Merck & Co Protein-based Therapeutics Product

Table 92. Merck & Co Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 93. Merck & Co Recent Development

Table 94. Takeda Company Details

Table 95. Takeda Business Overview

Table 96. Takeda Protein-based Therapeutics Product

Table 97. Takeda Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 98. Takeda Recent Development

Table 99. Merck KGaA Company Details

Table 100. Merck KGaA Business Overview

Table 101. Merck KGaA Protein-based Therapeutics Product

Table 102. Merck KGaA Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 103. Merck KGaA Recent Development

Table 104. Seagen Company Details

Table 105. Seagen Business Overview

Table 106. Seagen Protein-based Therapeutics Product

Table 107. Seagen Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 108. Seagen Recent Development

Table 109. Eli Lilly Company Details

Table 110. Eli Lilly Business Overview

Table 111. Eli Lilly Protein-based Therapeutics Product

Table 112. Eli Lilly Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 113. Eli Lilly Recent Development

Table 114. Ono Pharmaceutical Company Details

Table 115. Ono Pharmaceutical Business Overview

Table 116. Ono Pharmaceutical Protein-based Therapeutics Product

Table 117. Ono Pharmaceutical Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 118. Ono Pharmaceutical Recent Development

Table 119. Pfizer Company Details

Table 120. Pfizer Business Overview

Table 121. Pfizer Protein-based Therapeutics Product

Table 122. Pfizer Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 123. Pfizer Recent Development

Table 124. Regeneron Company Details

Table 125. Regeneron Business Overview

Table 126. Regeneron Protein-based Therapeutics Product

Table 127. Regeneron Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 128. Regeneron Recent Development

Table 129. Innovent Company Details

Table 130. Innovent Business Overview

Table 131. Innovent Protein-based Therapeutics Product

Table 132. Innovent Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 133. Innovent Recent Development

Table 134. Hengrui Medicine Company Details

Table 135. Hengrui Medicine Business Overview

Table 136. Hengrui Medicine Protein-based Therapeutics Product

Table 137. Hengrui Medicine Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 138. Hengrui Medicine Recent Development

Table 139. Sanofi Company Details

Table 140. Sanofi Business Overview

Table 141. Sanofi Protein-based Therapeutics Product

Table 142. Sanofi Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 143. Sanofi Recent Development

Table 144. Sobi Company Details

Table 145. Sobi Business Overview

Table 146. Sobi Protein-based Therapeutics Product

Table 147. Sobi Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 148. Sobi Recent Development

Table 149. Kanghong Pharma Company Details

Table 150. Kanghong Pharma Business Overview

Table 151. Kanghong Pharma Protein-based Therapeutics Product

Table 152. Kanghong Pharma Revenue in Protein-based Therapeutics Business (2020-2025) & (US$ Million)

Table 153. Kanghong Pharma Recent Development

Table 154. Research Programs/Design for This Report

Table 155. Key Data Information from Secondary Sources

Table 156. Key Data Information from Primary Sources

Table 157. Authors List of This Report

List of Figures

Figure 1. Protein-based Therapeutics Picture

Figure 2. Global Protein-based Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Protein-based Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Antibody-based Drugs Features

Figure 5. Fc Fusion Proteins Features

Figure 6. Anticoagulants Features

Figure 7. Blood Factors Features

Figure 8. Other Features

Figure 9. Global Protein-based Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Protein-based Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Immune Diseases Case Studies

Figure 12. Cancer Case Studies

Figure 13. Other Case Studies

Figure 14. Protein-based Therapeutics Report Years Considered

Figure 15. Global Protein-based Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Protein-based Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Protein-based Therapeutics Market Share by Region: 2024 VS 2031

Figure 18. Global Protein-based Therapeutics Market Share by Players in 2024

Figure 19. Global Top Protein-based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein-based Therapeutics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Protein-based Therapeutics Revenue in 2024

Figure 21. North America Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Protein-based Therapeutics Market Share by Country (2020-2031)

Figure 23. United States Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Protein-based Therapeutics Market Share by Country (2020-2031)

Figure 27. Germany Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Protein-based Therapeutics Market Share by Region (2020-2031)

Figure 35. China Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Protein-based Therapeutics Market Share by Country (2020-2031)

Figure 43. Mexico Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Protein-based Therapeutics Market Share by Country (2020-2031)

Figure 47. Turkey Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Protein-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. AbbVie Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 51. Johnson & Johnson Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 53. Gilead Sciences Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 54. Roche Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 56. Amgen Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 57. AstraZeneca Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 58. Merck & Co Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 59. Takeda Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 60. Merck KGaA Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 61. Seagen Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 62. Eli Lilly Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 63. Ono Pharmaceutical Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 64. Pfizer Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 65. Regeneron Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 66. Innovent Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 67. Hengrui Medicine Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 68. Sanofi Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 69. Sobi Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 70. Kanghong Pharma Revenue Growth Rate in Protein-based Therapeutics Business (2020-2025)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Therapeutic Protein Drug Market Research Report 2024

Global Plasma Protein Therapeutics Market Research Report 2025

Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Insights Forecast to 2030

Global Recombinant Protein Peptide Drug Market Research Report 2024

Global Recombinant Therapeutic Protein Market Research Report 2025

Global mRNA Therapy Market Research Report 2024

Recombinant Protein Therapeutics Market

Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Protein Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Protein based Fat Replacers Market

Global Protein Shot Market Research Report 2024

Global Protein Delivery Market Research Report 2024

Global Peptide Therapy Market Research Report 2025

Global Cell therapy platform Market Research Report 2024

Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Therapy Growth Factors Market Research Report 2024

Global Targeted Protein Degradation Technology Market Research Report 2024

Protein Degradation Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Protein Processing Service Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions